+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 60Years
All Genders
Healthy Volunteers
ID05012982

Immunometabolic Mechanisms of Blood Flow Restriction Training After Anterior Cruciate Ligament Reconstruction

Led by Yale University · Updated on 2025-12-03

20

Participants Needed

2

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are investigating how blood flow restriction BFR training affects immune cell metabolism and gene expression in people recovering from anterior cruciate ligament ACL reconstruction. This phase 4 study explores the impact of BFR on immunometabolism during rehabilitation to better understand its biological effects. The study uses a single-blind crossover design where participants experience both BFR and control sessions in random order. Participants will attend two training sessions at least one week apart. In one session, an AirBand device will be inflated to restrict blood flow by 60 in the femoral artery while an ultrasound probe monitors the artery. In the other session, participants will wear an uninflated AirBand as a control. A certified Personal Therapist will supervise all sessions to ensure safety and adherence. Throughout each session and at baseline, immediately after, and at 30 and 60 minutes post-exercise, researchers will measure changes in leukocyte metabolic gene expression, substrate preference, and concentrations of amino acids, glucose, lactate, fatty acids, insulin, glucagon, and catecholamines. Secondary measures include creatine kinase levels, patient-reported soreness, and baseline immunometabolic profiles. The total study duration involves two visits with monitoring of biological and self-reported outcomes.

CONDITIONS

Brief Title

Immunometabolic Mechanisms of Blood Flow Restriction (BFR) Training After Anterior Cruciate Ligament Reconstruction

Who Can Participate

Age: 18Years - 60Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed and dated informed consent form
  • Willingness to comply with all study procedures and attend two study visits at least 1 week apart
  • All genders, aged between 18 and 60 years
  • In good general health without medical conditions or prior injury increasing risk of further injury or illness by participating
Not Eligible

You will not qualify if you...

  • Serious medical conditions including cardiovascular, metabolic (diabetes), rheumatologic, pulmonary, or musculoskeletal disorders
  • Multiple ligament ruptures or trauma
  • Rheumatoid arthritis or other significant comorbidities
  • Lower extremity vascular pathology including history of deep vein thrombosis
  • History of sickle cell trait or disease
  • Use of anticoagulant medications
  • Pregnancy
  • Treatment with another investigational drug or intervention within one month before study start
  • Current smoker or tobacco use within 3 months before study start
  • Febrile illness within 2 weeks before study start

Research Team

R

Rachel Perry, PhD

A

Andin Fosam, BS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here